Royal Pharmaceutical Society
Open access article
The Royal Pharmaceutical Society has made this article free to access in order to help healthcare professionals stay informed about an issue of national importance.
To learn more about coronavirus, please visit: https://www.rpharms.com/resources/pharmacy-guides/wuhan-novel-coronavirus
The Royal Pharmaceutical Society (RPS) is working with government bodies, including the British High Commission (BHC) in India, to support pharmacy teams abroad as they face the challenges of COVID-19.
With NHS England, the RPS has teamed up with the BHC in India, the Indian Pharmaceutical Association, the Commonwealth Pharmacy Association and the International Pharmaceutical Federation (FIP) to share resources and expertise on tackling the COVID-19 pandemic.
A spokesperson for the RPS said that it was part of a clinical advisory group formed by NHS England and NHS Improvement (NHSE&I) “to discuss ideas and opportunities to work with colleagues in India on resources, shared learnings” and a series of webinars.
Prerana Issar, chief people officer at the NHS, said the pandemic “has highlighted how intertwined our healthcare systems truly are and leaders across the NHS rapidly provided support to India on their clinical priorities remotely”.
“We thank colleagues across the NHS, including at the RPS, for supporting this programme — this was a cutting-edge and dynamic team effort and I hope this pioneering global learning forum between health systems remains as a positive legacy from the pandemic.”
Ravi Sharma, director for England at the RPS, said: “The ongoing COVID-19 crisis in countries across the globe is truly distressing.
“[The RPS is] here to support pharmacy teams in the UK and across the world during this difficult time, and we are united with all pharmacy teams battling against the pandemic,” he added.
“It has been a pleasure to work collaboratively with the NHS on what we can do to show our support.”
READ MORE: Everything you need to know about the COVID-19 therapy trials
